Literature DB >> 30825953

Getting to the Heart of the Matter: A Review of Drug Interactions Between HIV Antiretrovirals and Cardiology Medications.

Pierre Giguère1, Salin Nhean2, Alice L Tseng3, Christine A Hughes4, Jonathan B Angel5.   

Abstract

The past 20 years have seen remarkable advances in the treatment of HIV such that most people diagnosed with HIV today can live long, healthy lives by taking antiretrovirals which are usually life-long. Advancements in antiretroviral therapy include the availability of well tolerated, single tablet regimens that are associated with a lower risk of drug-drug interactions. Despite this, many people living with HIV infection might be taking antiretroviral agents that are associated with significant drug-drug interactions. Because HIV infection itself is associated with cardiovascular complications and this population is living longer, concomitant use of antiretrovirals and medications to treat cardiovascular-related diseases is often required. For this reason, it is imperative that clinicians are aware of the potential for clinically significant drug-drug interactions between antiretroviral agents and cardiac medications as well as the useful HIV drug interaction resources that might provide guidance. Available data on significant interactions are summarized and suggested guidance regarding management is discussed.
Copyright © 2018 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Year:  2018        PMID: 30825953     DOI: 10.1016/j.cjca.2018.12.020

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  7 in total

Review 1.  The impact of SARS-CoV-2 treatment on the cardiovascular system: an updated review.

Authors:  Mohammed Ahmed Akkaif; Abubakar Sha'aban; Arturo Cesaro; Ammar Ali Saleh Jaber; Andrea Vergara; Ismaeel Yunusa; Abubakar Ibrahim Jatau; Mustapha Mohammed; G Saravana Govindasamy; Majed Ahmed Al-Mansoub; Muhamad Ali Sheikh Abdul Kader; Baharudin Ibrahim
Journal:  Inflammopharmacology       Date:  2022-06-14       Impact factor: 5.093

2.  COVID-19 and Cardiovascular Diseases.

Authors:  Babak Geraiely; Niloufar Samiei; Parham Sadeghipour; Azita H Talasaz; Seyedeh Hamideh Mortazavi; Roya Sattarzadeh Badkoubeh
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 3.  Drug-drug interactions with candidate medications used for COVID-19 treatment: An overview.

Authors:  Haleh Rezaee; Fariba Pourkarim; Samira Pourtaghi-Anvarian; Taher Entezari-Maleki; Touraj Asvadi-Kermani; Masoud Nouri-Vaskeh
Journal:  Pharmacol Res Perspect       Date:  2021-02

Review 4.  An update on drug-drug interactions between antiretroviral therapies and drugs of abuse in HIV systems.

Authors:  Nuti Desai; Leah Burns; Yuqing Gong; Kaining Zhi; Asit Kumar; Nathan Summers; Santosh Kumar; Theodore J Cory
Journal:  Expert Opin Drug Metab Toxicol       Date:  2020-08-31       Impact factor: 4.481

Review 5.  Cardiovascular Complications of COVID-19: Pharmacotherapy Perspective.

Authors:  Azita Hajhossein Talasaz; Hessam Kakavand; Benjamin Van Tassell; Maryam Aghakouchakzadeh; Parham Sadeghipour; Steven Dunn; Babak Geraiely
Journal:  Cardiovasc Drugs Ther       Date:  2020-07-15       Impact factor: 3.727

6.  Management of ST-segment-elevation myocardial infarction during the coronavirus disease 2019 (COVID-19) outbreak: Iranian"247" National Committee's position paper on primary percutaneous coronary intervention.

Authors:  Parham Sadeghipour; Azita H Talasaz; Vahid Eslami; Babak Geraiely; Mohammad Vojdanparast; Mojtaba Sedaghat; Abouzar Fakhr Moosavi; Saeed Alipour-Parsa; Bahram Aminian; Ata Firouzi; Samad Ghaffari; Massoud Ghasemi; Davood Kazemi Saleh; Alireza Khosravi; Javad Kojuri; Feridoun Noohi; Hamid Pourhosseini; Mojtaba Salarifar; Mohamad Reza Salehi; Hashem Sezavar; Mahmoud Shabestari; Abbas Soleimani; Payam Tabarsi; Amir Farhang Zand Parsa; Seifollah Abdi
Journal:  Catheter Cardiovasc Interv       Date:  2020-04-22       Impact factor: 2.585

Review 7.  How to overcome cardiovascular challenges in COVID-19 patients: a guide for common practice.

Authors:  Pegah Eslami; Mohammadreza Tabary; Arash Dooghaie-Moghadam; Isa Khaheshi
Journal:  Acta Biomed       Date:  2020-09-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.